Anzai като резултат Акредитивни писма jaqueta spike evolution membrana сметка пластичност кухня
Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets - ScienceDirect
Life | Free Full-Text | Structural and Phylogenetic Analysis of SARS-CoV-2 Spike Glycoprotein from the Most Widespread Variants | HTML
Evolution of the SARS-CoV-2 spike protein in the human host | Nature Communications
Frontiers | Structural Comparison of the SARS CoV 2 Spike Protein Relative to Other Human-Infecting Coronaviruses
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach - ScienceDirect
SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex | Science
Mutations arising in SARS-CoV-2 spike on sustained human-to-human transmission and human-to-animal passage - SARS-CoV-2 coronavirus - Virological
The Yin and Yang of SARS-CoV-2 Mutation and Evolution - Mayo Clinic Proceedings
Decoding SARS-CoV-2 Transmission and Evolution and Ramifications for COVID-19 Diagnosis, Vaccine, and Medicine | Journal of Chemical Information and Modeling
The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles - Journal of Biological Chemistry
virus - Evolution of new virus strains | Britannica
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes | Science
Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development
Viruses | Free Full-Text | Mutations and Evolution of the SARS-CoV-2 Spike Protein | HTML
Frontiers | SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Frontiers | Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
Exposing structural variations in SARS-CoV-2 evolution | Scientific Reports
Frontiers | Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
Evolution of neurovirulent Zika virus | Science
Prefusion spike protein conformational changes are slower in SARS-CoV-2 than in SARS-CoV-1 - Journal of Biological Chemistry
SARS-CoV-2 spike protein characteristics responsible for viral evolution in human hosts
The evolution of the SARS-CoV-2 spike protein
Membrane transporter identification and modulation via adaptive laboratory evolution - ScienceDirect
EXOSOMES - The Next Evolution in Therapy Delivery Beyond the Cell Membrane: The Promise of Exosomes
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis: Trends in Molecular Medicine